Effects of Secondary Left-sided Portal Hypertension on the Radical Operation Rate and Prognosis in Patients with Pancreatic Cancer

  • Zhang, Shuo (Department of Obstetrics and Gynecology, Chinese PLA Air Force General Hospital) ;
  • Wen, Dong-Qing (The Fourth Research Office, Air Force Aviation Medicine Institute) ;
  • Kong, Ya-Lin (Department of Hepatobiliary Surgery, Chinese PLA Air Force General Hospital) ;
  • Li, Ya-Li (Department of Obstetrics and Gynecology, Chinese PLA General Hospital) ;
  • Zhang, Hong-Yi (Department of Hepatobiliary Surgery, Chinese PLA Air Force General Hospital)
  • Published : 2014.03.01


Objective: To investigate the effects of secondary left-sided portal hypertension (LSPH) on the radical operation rate of patients with pancreatic cancer and systemically evaluate the prognosis of patients with LSPH secondary to pancreatic cancer after radical surgery. Materials and Methods: The data of patients with pancreatic cancer who underwent laparotomy over a 15-year period in Department of Hepatobiliary Surgery of Chinese PLA Air Force General Hospital from Jan. 1, 1997, to Jun. 30, 2012 was retrospectively reviewed. Results: A total of 362 patients with pancreatic cancer after laparotomy were selected, including 73 with LSPH and 289 without LSPH. Thirty-five patients with LSPH (47.9%) and 147 without non-LSPH (50.9%) respectively underwent radical operations. No significant difference was found between these two groups regarding the total resection rate and stratified radical resection rate according to different pathological types and cancer locations. The mean and median survival time of patients after radical operation in LSPH group were $13.9{\pm}1.3$ months and 14.8 months, respectively, while those in non-LSPH group were $22.6{\pm}1.4$ months and 18.4 months, respectively(P<0.05). Conclusions: Radical operations for pancreatic cancer and secondary LSPH are safe and effective. Because high-grade malignancy and poor prognosis are closely associated, the decision for radical surgery should be made more meticulously for the patients with pancreatic cancer.


  1. Zhang JF, Hua R, Sun YW, et al (2013). Influence of perineural invasion on survival and recurrence in patients with resected pancreatic cancer. Asian Pac J Cancer Prev, 14, 5133-9.
  2. Wang L, Liu GJ, Chen YX, et al (2012). Sinistral portal hypertension: clinical features and surgical treatment of chronic splenic vein occlusion. Med Princ Pract, 21, 20-3.
  3. Xu LS, Liu JH, Lin P, et al (2010). Clinical features of panereatic disease-associated portal hypertension. Nan Fang Yi Ke Da Xue Xue Bao, 30, 1234-6.
  4. Yamaguchi T, Takahashi H, Kagawa R, et al (2005). Nonfunctioning pancreatic endocrine tumor presenting with hemorrhage from isolated gastric varices. Am Surg, 71, 1027-30.
  5. Zahir ST, Arjmand A, Kargar S, et al (2013). Incidence and trends of malignant and benign pancreatic lesions in Yazd, Iran between 2001 and 2011. Asian Pac J Cancer Prev, 14, 2631-5.
  6. Shah SR, Deshmukh HL, Mathur SK (2003). Extensive portal and splenic vein thrombosis: differences in hemodynamics and management. Hepatogastroenterology, 50, 1085-9.
  7. Kokabi N, Lee E, Echevarria C, et al (2010). Sinistral portal hypertension: presentation, radiological findings, and treatment options - a case report. J Radiol Case Rep, 4, 14-20.
  8. Koklu S, Gultuna S, Yuksel O (2010). Left-sided portal hypertension: 5-years follow-up. Hepatogastroenterology, 57, 1-2.
  9. Ozaki K, Sanada J, Gabata T, et al (2010). Severe intestinal bleeding due to sinistral portal hypertension after pyloruspreserving pancreatoduodenectomy. Abdom Imaging, 35, 643-5.
  10. Strasberg SM, Bhalla S, Sanchez LA, et al (2011). Pattern of venous collateral development after splenic vein occlusion in an extended Whipple procedure: comparison with collateral vein pattern in cases of sinistral portal hypertension. J Gastrointest Surg, 15, 2070-9.
  11. Strasberg SM, Sanchez LA, Hawkins WG, et al (2012). Resection of tumors of the neck of the pancreas with venous invasion: the "Whipple at the Splenic Artery (WATSA)" procedure. J Gastrointest Surg, 16, 1048-54.
  12. Thompson RJ, Taylor MA, McKie LD, et al (2006). Sinistral portal hypertension. Ulster Med J, 75, 175-7.
  13. Tsuchida S, Ku Y, Fukumoto T, et al (2003). Isolated gastric varices resulting from iatrogenic splenic vein occlusion: report of a case. Surg Today, 33, 542-4.
  14. Tzeng YD, Liu SI, Tsai CC (2012). An unusual cause of haematemesis: left-sided portal hypertension due to a large pancreatic tumour. Dig Liver Dis, 44, e12.
  15. Wang CF (2011). How to operate successfully for pancreatic cancer. Zhonghua Yi Xue Za Zhi, 91, 3100-2.
  16. Chen WQ, Liang D, Zhang SW, et al (2013). Pancreatic cancer incidence and mortality patterns in china, 2009. Asian Pac J Cancer Prev, 14, 7321-4.
  17. Cakmak O, Parildar M, Oran I, et al (2005). Sinistral portal hypertension; imaging findings and endovascular therapy. Abdom Imaging, 30, 208-13.
  18. Chang CY (1999). Pancreatic adenocarcinoma presenting as sinistral portal hypertension: an unusual presentation of pancreatic cancer. Yale J Biol Med, 72, 295-300.
  19. Canyilmaz E, Serdar L, Uslu GH, et al (2013). Evaluation of prognostic factors and survival results in pancreatic carcinomas in Turkey. Asian Pac J Cancer Prev, 14, 6573-8.
  20. Cheung R (2013). Racial and social economic factors impact on the cause specific survival of pancreatic cancer: a SEER survey. Asian Pac J Cancer Prev, 14, 159-63.
  21. Ding JZ, Yan JQ, Yang WP, et al (2012). Multi-visceral resection of malignant tumors with left-sided portal hypertension. Hepatogastroenterology, 59, 1277-81.
  22. Maleknai R, Nadir A (2008). Atypical presentation and etiology of left-sided portal hypertension. Dig Dis Sci, 53, 1428-9.
  23. Nakamura S, Takayama Y, Kuboki Y, et al (2010). A case of solid pseudopapillary neoplasm of the pancreas presenting with left-sided extrahepatic portal hypertension. Intern Med, 49, 1749-53.
  24. Ito K, Kudo A, Nakamura N, et al (2008). Leftsided portal hypertension caused by serous cystadenoma of the pancreas: Report of a case. Surg Today, 38, 184-7.
  25. Arnaoutakis D, Eckhauser F (2011). Safety and effectiveness of splenic vein to inferior mesenteric vein anastomosis during pancreaticoduodenectomy: comment on “Splenic veininferior mesenteric vein anastomosis to lessen left-sided portal hypertension after pancreaticoduodenectomy with concomitant vascular resection”. Arch Surg, 146, 1381-2.